Cargando…

Role of ultrasound, clinical and scintigraphyc parameters to predict malignancy in thyroid nodule

BACKGROUND: This study aimed to evaluate clinical, laboratory, ultrasound (US) and scintigraphyc parameters in thyroid nodule and to develop an auxiliary model for clinical application in the diagnosis of malignancy. METHODS: We assessed 143 patients who were surgically treated at a single center, 6...

Descripción completa

Detalles Bibliográficos
Autores principales: Maia, Frederico FR, Matos, Patrícia S, Silva, Bradley P, Pallone, Ana T, Pavin, Elizabeth J, Vassallo, José, Zantut-Wittmann, Denise E
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3073950/
https://www.ncbi.nlm.nih.gov/pubmed/21426548
http://dx.doi.org/10.1186/1758-3284-3-17
_version_ 1782201668753948672
author Maia, Frederico FR
Matos, Patrícia S
Silva, Bradley P
Pallone, Ana T
Pavin, Elizabeth J
Vassallo, José
Zantut-Wittmann, Denise E
author_facet Maia, Frederico FR
Matos, Patrícia S
Silva, Bradley P
Pallone, Ana T
Pavin, Elizabeth J
Vassallo, José
Zantut-Wittmann, Denise E
author_sort Maia, Frederico FR
collection PubMed
description BACKGROUND: This study aimed to evaluate clinical, laboratory, ultrasound (US) and scintigraphyc parameters in thyroid nodule and to develop an auxiliary model for clinical application in the diagnosis of malignancy. METHODS: We assessed 143 patients who were surgically treated at a single center, 65% (93) benign vs. 35% (50) malignant lesions at final histology (1998-2008). The clinical, laboratory, scintigraphyc and US features were compared and a prediction model was designed after the multivariate analysis. RESULTS: There were no differences in gender, serum TSH and FT4 levels, thyroid auto-antibodies (TAb), thyroid dysfunction and scintigraphyc results (P = 0.33) between benign and malignant nodule groups. The sonographic study showed differences when the presence of suspected characteristics was found in the nodules of the malignant lesions group, such as: microcalcifications, central flow, border irregularity and hypoechogenicity. After the multivariate analysis the model obtained showed age (>39 years), border irregularity, microcalcifications and nodule size over 2 cm as predictive factors of malignancy, featuring 81.7% of accuracy. CONCLUSIONS: This study confirmed a significant increase of risk for malignancy in patients of over 39 years and with suspicious features at US.
format Text
id pubmed-3073950
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-30739502011-04-12 Role of ultrasound, clinical and scintigraphyc parameters to predict malignancy in thyroid nodule Maia, Frederico FR Matos, Patrícia S Silva, Bradley P Pallone, Ana T Pavin, Elizabeth J Vassallo, José Zantut-Wittmann, Denise E Head Neck Oncol Research BACKGROUND: This study aimed to evaluate clinical, laboratory, ultrasound (US) and scintigraphyc parameters in thyroid nodule and to develop an auxiliary model for clinical application in the diagnosis of malignancy. METHODS: We assessed 143 patients who were surgically treated at a single center, 65% (93) benign vs. 35% (50) malignant lesions at final histology (1998-2008). The clinical, laboratory, scintigraphyc and US features were compared and a prediction model was designed after the multivariate analysis. RESULTS: There were no differences in gender, serum TSH and FT4 levels, thyroid auto-antibodies (TAb), thyroid dysfunction and scintigraphyc results (P = 0.33) between benign and malignant nodule groups. The sonographic study showed differences when the presence of suspected characteristics was found in the nodules of the malignant lesions group, such as: microcalcifications, central flow, border irregularity and hypoechogenicity. After the multivariate analysis the model obtained showed age (>39 years), border irregularity, microcalcifications and nodule size over 2 cm as predictive factors of malignancy, featuring 81.7% of accuracy. CONCLUSIONS: This study confirmed a significant increase of risk for malignancy in patients of over 39 years and with suspicious features at US. BioMed Central 2011-03-22 /pmc/articles/PMC3073950/ /pubmed/21426548 http://dx.doi.org/10.1186/1758-3284-3-17 Text en Copyright ©2011 Maia et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Maia, Frederico FR
Matos, Patrícia S
Silva, Bradley P
Pallone, Ana T
Pavin, Elizabeth J
Vassallo, José
Zantut-Wittmann, Denise E
Role of ultrasound, clinical and scintigraphyc parameters to predict malignancy in thyroid nodule
title Role of ultrasound, clinical and scintigraphyc parameters to predict malignancy in thyroid nodule
title_full Role of ultrasound, clinical and scintigraphyc parameters to predict malignancy in thyroid nodule
title_fullStr Role of ultrasound, clinical and scintigraphyc parameters to predict malignancy in thyroid nodule
title_full_unstemmed Role of ultrasound, clinical and scintigraphyc parameters to predict malignancy in thyroid nodule
title_short Role of ultrasound, clinical and scintigraphyc parameters to predict malignancy in thyroid nodule
title_sort role of ultrasound, clinical and scintigraphyc parameters to predict malignancy in thyroid nodule
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3073950/
https://www.ncbi.nlm.nih.gov/pubmed/21426548
http://dx.doi.org/10.1186/1758-3284-3-17
work_keys_str_mv AT maiafredericofr roleofultrasoundclinicalandscintigraphycparameterstopredictmalignancyinthyroidnodule
AT matospatricias roleofultrasoundclinicalandscintigraphycparameterstopredictmalignancyinthyroidnodule
AT silvabradleyp roleofultrasoundclinicalandscintigraphycparameterstopredictmalignancyinthyroidnodule
AT palloneanat roleofultrasoundclinicalandscintigraphycparameterstopredictmalignancyinthyroidnodule
AT pavinelizabethj roleofultrasoundclinicalandscintigraphycparameterstopredictmalignancyinthyroidnodule
AT vassallojose roleofultrasoundclinicalandscintigraphycparameterstopredictmalignancyinthyroidnodule
AT zantutwittmanndenisee roleofultrasoundclinicalandscintigraphycparameterstopredictmalignancyinthyroidnodule